Aminologics Statistics

Total Valuation

Aminologics has a market cap or net worth of KRW 80.27 billion. The enterprise value is 46.91 billion.

Market Cap	80.27B
Enterprise Value	46.91B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Aminologics has 87.83 million shares outstanding. The number of shares has increased by 3.44% in one year.

Current Share Class	n/a
Shares Outstanding	87.83M
Shares Change (YoY)	+3.44%
Shares Change (QoQ)	+9.90%
Owned by Insiders (%)	0.64%
Owned by Institutions (%)	0.20%
Float	59.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.90
PB Ratio	1.71
P/TBV Ratio	1.65
P/FCF Ratio	11.54
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-28.96
EV / Sales	2.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	6.75

Financial Position

The company has a current ratio of 10.71, with a Debt / Equity ratio of 0.04.

Current Ratio	10.71
Quick Ratio	9.22
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	0.29
Interest Coverage	-25.81

Financial Efficiency

Return on equity (ROE) is -3.05% and return on invested capital (ROIC) is -2.45%.

Return on Equity (ROE)	-3.05%
Return on Assets (ROA)	-2.35%
Return on Invested Capital (ROIC)	-2.45%
Return on Capital Employed (ROCE)	-4.11%
Revenue Per Employee	441.85M
Profits Per Employee	-42.63M
Employee Count	38
Asset Turnover	0.29
Inventory Turnover	1.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.71% in the last 52 weeks. The beta is 0.85, so Aminologics's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-44.71%
50-Day Moving Average	931.82
200-Day Moving Average	1,120.07
Relative Strength Index (RSI)	45.39
Average Volume (20 Days)	61,444

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aminologics had revenue of KRW 16.79 billion and -1.62 billion in losses. Loss per share was -18.00.

Revenue	16.79B
Gross Profit	3.38B
Operating Income	-2.15B
Pretax Income	-1.10B
Net Income	-1.62B
EBITDA	-1.69B
EBIT	-2.15B
Loss Per Share	-18.00

Full Income Statement

Balance Sheet

The company has 35.38 billion in cash and 2.02 billion in debt, giving a net cash position of 33.36 billion or 379.88 per share.

Cash & Cash Equivalents	35.38B
Total Debt	2.02B
Net Cash	33.36B
Net Cash Per Share	379.88
Equity (Book Value)	51.70B
Book Value Per Share	535.57
Working Capital	42.18B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.47 billion and capital expenditures -511.50 million, giving a free cash flow of 6.95 billion.

Operating Cash Flow	7.47B
Capital Expenditures	-511.50M
Free Cash Flow	6.95B
FCF Per Share	79.18

Full Cash Flow Statement

Margins

Gross margin is 20.16%, with operating and profit margins of -12.82% and -9.65%.

Gross Margin	20.16%
Operating Margin	-12.82%
Pretax Margin	-6.58%
Profit Margin	-9.65%
EBITDA Margin	-10.05%
EBIT Margin	-12.82%
FCF Margin	41.42%

Dividends & Yields

Aminologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.44%
Shareholder Yield	-3.44%
Earnings Yield	-2.02%
FCF Yield	8.66%

Stock Splits

The last stock split was on October 23, 2009. It was a forward split with a ratio of 5.

Last Split Date	Oct 23, 2009
Split Type	Forward
Split Ratio	5

Scores

Aminologics has an Altman Z-Score of 13.01.

Altman Z-Score	13.01
Piotroski F-Score	n/a